A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines
Conditions
- Moderate to Severe Glabellar Lines
Interventions
- BIOLOGICAL: QM1114-DP
- BIOLOGICAL: OnabotulinumtoxinA
- BIOLOGICAL: Placebo
Sponsor
Galderma R&D